Validated Stability-Indicating HPLC and HPTLC Methods for the Determination of Ritonavir in Bulk Powder and in Capsules

被引:12
作者
Abdelhay, Mohammad H. [1 ]
Gazy, Azza A. [1 ]
Shaalan, Rasha A. [1 ]
Ashour, Heba K. [1 ]
机构
[1] Univ Alexandria, Fac Pharm, Dept Pharmaceut Analyt Chem, Alexandria, Egypt
关键词
HPLC; HPTLC; ritonavir; soft gelatin capsules; stability-indicating; PERFORMANCE LIQUID-CHROMATOGRAPHY; ACTIVE METABOLITE M8; PROTEASE INHIBITORS; HUMAN PLASMA; HUMAN SERUM; SAQUINAVIR; LOPINAVIR; QUANTIFICATION; NELFINAVIR; AMPRENAVIR;
D O I
10.6227/jfda.2012200428
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Two sensitive and reproducible methods were described for the quantitative determination of the antireteroviral drug ritonavir in the presence of its degradation products. The first method was based on high performance liquid chromatographic (H PLC) separation of the drug from its stress degradation products with the use of a reversed phase Agilent Eclipse XDB-C18 column (5 mu m, 4.6 x 150 mm) and a mobile phase consisting of acetonitrile : 0.05 M phosphoric acid (55 : 45, v/v) at a flow rate of 1.0 mL/min. The retention time of the drug was found to be 4.82 +/- 0.002 min. Quantification was achieved with diode array detection (DAD) at 210 nm based on peak area and a linear calibration curve in the concentration range of 1-500 mu g/mL. The proposed method made use of diode array detection as a tool for peak purity and identification. The second method involved a high performance thin layer chromatographic (HPTLC) separation followed by densitometric measurement of the spots at 240 nm. The separation was carried out on Fluka TLC aluminium sheets of silica gel with fluorescent indicator (254) nm and the mobile phase was acetonitrile - water (1 : 2, v/v), adjusted to pH 5.0 using 1 M orthophosphoric acid solution. The proposed procedure gave compact spots for ritonavir (retention factor, R-f = 0.41 +/- 0.014). The linear regression equation was generated by least-squares treatment of the calibration data in the range of 0.8-12.5 mu g/spot. The reliability and analytical performance of the proposed methods, including linearity, range, precision, accuracy, detection and quantitation limits, were statistically validated. The proposed methods were applied to Norvir capsules and no chromatographic interference was observed. When ritonavir was subjected to stress conditions; according to ICH guidelines, the proposed methods could effectively separate the drug from its degradation products, and were thus considered as good stability-indicating procedures.
引用
收藏
页码:963 / 973
页数:11
相关论文
共 27 条
[1]   Determination of saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography and the analytical error function [J].
Albert, V ;
Modamio, P ;
Lastra, CF ;
Mariño, EL .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (04) :835-840
[2]  
[Anonymous], 2010, BRIT PHARMACOPEIA, p[1853, A586]
[3]  
[Anonymous], CLARKS ANAL DRUGS PO
[4]  
[Anonymous], 2011, US PHARM, P693
[5]  
[Anonymous], 1993, ICH STAB TEST NEW DU
[6]  
Araujo A. A., 2002, FIP WORLD C, V62, P55
[7]   Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection [J].
Dailly, E ;
Raffi, F ;
Jolliet, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 813 (1-2) :353-358
[8]   Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography [J].
Frappier, S ;
Breilh, D ;
Diarte, E ;
Ba, B ;
Ducint, D ;
Pellegrin, JL ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 714 (02) :384-389
[9]  
Gennaro A. R., 2007, REMINGTON SCI PRACTI
[10]   Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography [J].
Granda, BW ;
Giancarlo, GM ;
von Moltke, LL ;
Greenblatt, DJ .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1998, 40 (04) :235-239